Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
BioGraphene logo — Advance Graphene-Based Technology to Save and Improve People...

BioGraphene

Advance Graphene-Based Technology to Save and Improve People's Lives

Founded 2017 United States Los Angeles, United States 3 employees Series Unknown Biotechnology, Health Care +1

General Information

Company Name BioGraphene
Founded Year 2017
Location United States Los Angeles, United States +2
Employees 3
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when BioGraphene moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About BioGraphene

BioGraphene is a biotech startup focused on revolutionizing the treatment of neurodegenerative diseases through advanced graphene-based drugs. The company's slogan "Advance Graphene-Based Technology to Save and Improve People's Lives" encapsulates its mission to make a meaningful impact on healthcare. Founded in 2017 and headquartered in the United States, BioGraphene is a spin-off from Seoul National University and officially established as a legal entity in California in June 2020. The company operates within the Biotechnology, Health Care, and Pharmaceutical sectors. In January 2021, BioGraphene secured a significant Venture Round investment from WONIK Investment Partners, signifying a crucial milestone in its growth trajectory. This financial backing not only provides the necessary resources for research and development but also serves as a vote of confidence from a prominent investor in the industry. BioGraphene's focus on addressing challenging conditions such as Parkinson's disease, Alzheimer's disease, and Niemann-Pick disease type C (NPC) positions the company as a potential game-changer in the field of neurodegenerative disease therapeutics.

Taxonomy: Biotech startup, Graphene-based drugs, Neurodegenerative diseases, Parkinson's disease, Alzheimer's disease, Niemann-Pick disease type C, Spin-off company, Seoul National University, California, Biomedical applications, Nanomedicines, Lysosomal storage diseases, Rare diseases, Graphene technology, Nanotechnology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Unknown 1
WONIK Investment Partners
01 Jan 2021

BioGraphene Alternatives & Competitors

BioGraphene vs
Satori Pharmaceuticals
Satori Pharmaceuticals

Pioneering advanced therapies for Alzheimer's, Parkinson's, and other neurodegenerative diseases.

Series Unknown
Health Care, Pharmaceutical
BioGraphene vs
T3D Therapeutics, Inc.
T3D Therapeutics, Inc. United States

Developing a potentially disease-modifying, new drug treatment for Alzheimer’s and other neurodegene...

Series Unknown
12 employees
Biotechnology
BioGraphene vs
Neuron23
Neuron23 United States

Combining cutting-edge science, human genetics, and a patient-centered approach to transform how we...

Series D
28 employees
Compare BioGraphene vs Neuron23

FAQ About BioGraphene

Advance Graphene-Based Technology to Save and Improve People's Lives
BioGraphene was founded in 2017.
BioGraphene is headquartered in Los Angeles, United States.
BioGraphene operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
BioGraphene has approximately 3 employees.
BioGraphene has completed 1 funding round. The latest funding stage is Series Unknown.
Top alternatives and competitors to BioGraphene include Satori Pharmaceuticals, T3D Therapeutics, Inc., Neuron23, Moredun Research Institute, Amira Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioGraphene and Satori Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BioGraphene and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy